<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
xmlns:EMSArticle="http://webdoc.advanstar.com/rss/module/EMSArticle"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://pharmtech.findpharma.com/pharmtech/servlet/pharmtech_full.rss">
    <title>Pharmaceutical Technology Magazine</title>

    <link>http://pharmtech.findpharma.com/pharmtech</link>

    <description>A publication providing practical information on pharmaceutical manufacturing. Content focuses on
    applied R&amp;amp;D technology, process control and computer-integrated manufacturing, biotechnology and technical
    management.</description>

    <items>
      <rdf:Seq>
        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/FTC-Issues-Report-on-Authorized-Generics/ArticleStandard/Article/detail/608013?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Chroma-Form-Devel/ArticleStandard/Article/detail/607999?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/US-Marshalls-Seize-Caracos-Drug-Products-at-Three-/ArticleStandard/Article/detail/608010?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Technology-Approaches-to-Quality-Management---Spar/ArticleStandard/Article/detail/608577?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/USP-Collaborates-with-Asian-Authorities/ArticleStandard/Article/detail/608009?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/UK-Strengthens-Drug-Supply-Chain/ArticleStandard/Article/detail/608006?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Cleaning-Validation-for-Pharmaceutical-Manufacturi/ArticleStandard/Article/detail/515954?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Avoiding-Project-Delays-Caused-by-Formulation-Chan/ArticleStandard/Article/detail/607230?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Booth-Preview/ArticleStandard/Article/detail/607201?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Watson-to-Acquire-Arrow-for-175-Billion/ArticleStandard/Article/detail/606176?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Aqueous-Cleaning-for-Pharmaceutical-Applications/ArticleStandard/Article/detail/476613?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/Former-Senate-Leaders-Support-Follow-On-Biologics-/ArticleStandard/Article/detail/606161?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Sunshine-Act-Still-Pending-before-Senate-Committee/ArticleStandard/Article/detail/606159?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/European-Fine-Chemicals-Group-Issues-Assessment-To/ArticleStandard/Article/detail/606178?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Synta-and-GSK-End-Agreeme/ArticleStandard/Article/detail/606500?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/New-FDA-and-ICH-Guidelines/ArticleStandard/Article/detail/605406?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Avoiding-Project-Delays-Caused-by-Formulation-Chan/ArticleStandard/Article/detail/605324?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Approved-New-Molecular-Entities/ArticleStandard/Article/detail/605350?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Industry-Spending-Facts/ArticleStandard/Article/detail/605416?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/FDA-Commissioner-Hamburg-Discusses-Drug-Regulation/ArticleStandard/Article/detail/605500?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Industry-Events-for-2009ndash2010/ArticleStandard/Article/detail/605349?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/FTC-Report-on-Follow-on-Biologics-Sparks-Congressi/ArticleStandard/Article/detail/604402?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Harmonization-Steps-Move-Forward-in-Tokyo/ArticleStandard/Article/detail/604405?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Industry-Health-Agencies-Respond-to-Influenza-Pand/ArticleStandard/Article/detail/604398?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Dr-Reddy-and-GSK-Form-Pac/ArticleStandard/Article/detail/604472?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Could-We-Make-Large-Molecules-with-Less-Labor/ArticleStandard/Article/detail/603746?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/June-2009-Editors-Picks-Products-from-Bullard-and-/ArticleStandard/Article/detail/603608?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation/Draft-Guidance-Issued-for-Injectors-Development/ArticleStandard/Article/detail/603740?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Kemwell-To-Build-Biologics-Manufacturing-Facility-/ArticleStandard/Article/detail/602702?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Mylan-COO-Testifies-on-Pay-to-Delay-Patent-Settlem/ArticleStandard/Article/detail/602700?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/GAO-Recommends-That-FDA-Ensure-Data-Security-withi/ArticleStandard/Article/detail/602699?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/European-Commission-Wont-Pursue-Directive-for-Exci/ArticleStandard/Article/detail/602697?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-and-Talecris-Terminat/ArticleStandard/Article/detail/602720?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/Report-From-India-A-new-patent-battleground-has-fo/ArticleStandard/Article/detail/603163?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Draft-Guidance-Issued-for-Injectors-Development/ArticleStandard/Article/detail/602698?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/FDA-Issues-Guidance-on-Medication-Guide-Statements/ArticleStandard/Article/detail/602695?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/MHRA-Seeks-Improved-Legislative-Framework/ArticleStandard/Article/detail/602701?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Best-Practices-in-the-Supply-Chain/ArticleStandard/Article/detail/601481?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Bleak-Times-for-the-Global-Biotech-Industry/ArticleStandard/Article/detail/601471?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Limits-to-Growth/ArticleStandard/Article/detail/601914?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/THE-IMPORTANCE-OF-ON-DOSE-TECHNOLOGIES-IN-THE-FIGH/ArticleStandard/Article/detail/601784?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/House-Introduces-Discussion-Draft-for-Drug-and-Foo/ArticleStandard/Article/detail/601252?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/US-and-16-States-Sue-Wyeth-over-Medicaid-Discounts/ArticleStandard/Article/detail/601246?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-and-Merck-Col/ArticleStandard/Article/detail/601645?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/EU-May-Change-Direct-to-Consumer-Rules/ArticleStandard/Article/detail/601259?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/FDA-Issues-Guidance-on-Submitting-Establishment-Re/ArticleStandard/Article/detail/601247?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Genetic-Link-to-Drug-Induced-Liver-Injury-Found/ArticleStandard/Article/detail/601260?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Drug-Serialization-and-Supply-Chain-Security/ArticleStandard/Article/detail/601169?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Mapping-Opportunities-for-Patent-Positions/ArticleStandard/Article/detail/600805?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation+Article/Operator-Error/ArticleStandard/Article/detail/600806?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Testing+Article/Charting-a-Pathway-to-Follow-On-Biologics/ArticleStandard/Article/detail/600817?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Report-From-Ireland/ArticleStandard/Article/detail/600811?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Inside+Standards/Quality-Trio-Takes-Final-Shape/ArticleStandard/Article/detail/600815?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/In-the-Spotlight/ArticleStandard/Article/detail/600810?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Package-Design-Boosts-Patient-Compliance/ArticleStandard/Article/detail/600816?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/Quarantine-at-a-Glance/ArticleStandard/Article/detail/601628?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Pharma-Capsules/ArticleStandard/Article/detail/600813?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Beneath-the-Surface/ArticleStandard/Article/detail/600812?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Quality-in-Quality-Out/ArticleStandard/Article/detail/601167?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Truth-and-Transparency/ArticleStandard/Article/detail/600808?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Outsourcing-Clinical-Trial-Materials/ArticleStandard/Article/detail/600809?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/FDA-Waves-a-Big-Stick/ArticleStandard/Article/detail/600814?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Penny-Wise-Pound-Foolish/ArticleStandard/Article/detail/600807?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Initial-Solvent-Screening-of-Carbamazepine-Cimetid/ArticleStandard/Article/detail/601168?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Pharmacosomes-A-Potential-Alternative-to-Conventio/ArticleStandard/Article/detail/601891?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Bulk-Inspection-of-Tablets-Symetix-Applicaton-Note/ArticleStandard/Article/detail/601279?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/FDAs-Question-Based-Review-Initiative-for-Generic-/ArticleStandard/Article/detail/600572?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/Attorney-Sentenced-to-Jail-for-Illegally-Distribut/ArticleStandard/Article/detail/600069?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-Forms-Licensing-Ag/ArticleStandard/Article/detail/600299?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Static-Electricity-The-Hidden-Danger/ArticleStandard/Article/detail/600996?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Tablet-Pro/ArticleStandard/Article/detail/517506?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Novartis-Gains-Exclusive-Option-to-Acquire-Elixir-/ArticleStandard/Article/detail/600067?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/HHS-Orders-H1N1-Vaccines-and-Vaccine-Antigen/ArticleStandard/Article/detail/600054?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/ADM-Plans-Green-Production-for-USP-Grade-Propylene/ArticleStandard/Article/detail/600065?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Static-Electricity-The-Hidden-Danger-Newson-Gale-W/ArticleStandard/Article/detail/600448?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Issues-Draft-Guidance-on-Presenting-Risk-Infor/ArticleStandard/Article/detail/600057?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/EFPIA-to-Launch-Anticounterfeiting-Pilot-in-Sweden/ArticleStandard/Article/detail/600062?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/USP-lt231gt-Heavy-Metals-Webcast/ArticleStandard/Article/detail/600132?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Versatrol-Controlled-Release-Softgel-Drug-Delivery/ArticleStandard/Article/detail/599418?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/PhRMA-Supports-Obamas-Healthcare-Reform-Initiative/ArticleStandard/Article/detail/599063?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Prefilled-Syringes-Growing-More-Popular/ArticleStandard/Article/detail/599068?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/EMEA-Releases-Draft-Advanced-Therapy-Medicinal-Pro/ArticleStandard/Article/detail/599061?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/European-Commission-Investigates-Biotech-Industry/ArticleStandard/Article/detail/599067?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Pharmacia-May-Pay-212M-in-Medicaid-Fraud-Case/ArticleStandard/Article/detail/599057?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/WHO-GSK-Provide-Update-on-Pandemic-Flu-Production/ArticleStandard/Article/detail/599059?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Hamburg-to-Take-Hold-of-FDA/ArticleStandard/Article/detail/599052?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Teva-and-Lonza-Joint-Vent/ArticleStandard/Article/detail/599148?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Teaching-a-New-Robot-Old-Tricks/ArticleStandard/Article/detail/598567?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/May-2009-Editors-Picks-Products-from-Continental-D/ArticleStandard/Article/detail/598570?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Pharmaceutical-Packaging-and-ePedigree-Requirement/ArticleStandard/Article/detail/598569?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Requests-Largest-Ever-Budget-Increase/ArticleStandard/Article/detail/597992?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-Forms-Pact-with-Aspen/ArticleStandard/Article/detail/598063?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/THE-IMPORTANCE-OF-ON-DOSE-TECHNOLOGIES-IN-THE-FIGH/ArticleStandard/Article/detail/598516?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Sanofi-aventis-To-Build-New-Vaccine-Manufacturing-/ArticleStandard/Article/detail/597995?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/FDA-Issues-First-Sentinel-Initiative-Project-Repor/ArticleStandard/Article/detail/597996?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/HPAPI-Manufacturing-Capability/ArticleStandard/Article/detail/598449?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Aqueous-Critical-Cleaning-in-Pharmaceutical-Manufa/ArticleStandard/Article/detail/515944?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Modern-tools-for-hopper-design/ArticleStandard/Article/detail/597324?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/How-to-Make-a-Swine-Flu-Vaccine/ArticleStandard/Article/detail/597284?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Sanofi-aventis-Plans-Biopharmaceutical-Investment/ArticleStandard/Article/detail/596941?ref=25" />
      </rdf:Seq>
    </items>

    <dc:date>2009-07-03T23:13:46Z</dc:date>
  </channel>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/FTC-Issues-Report-on-Authorized-Generics/ArticleStandard/Article/detail/608013?ref=25">

    <title>FTC Issues Report on Authorized Generics</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/FTC-Issues-Report-on-Authorized-Generics/ArticleStandard/Article/detail/608013?ref=25</link>

    <description>The Federal Trade Commission (FTC) last week issued an interim report that examined the effects of
    authorized generics on competition in the prescription drug market.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/608013null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Chroma-Form-Devel/ArticleStandard/Article/detail/607999?ref=25">

    <title>Company and People Notes: GSK and Chroma Form Development Pact; Siemen's Healthcare Appoints US CEO;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Chroma-Form-Devel/ArticleStandard/Article/detail/607999?ref=25</link>

    <description>Also, Wyeth and Catalyst sign agreement; FDA seeks public opinion about tobacco regulation; Catalent
    appoints VP of quality and regulatory affairs; more...</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607999null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/US-Marshalls-Seize-Caracos-Drug-Products-at-Three-/ArticleStandard/Article/detail/608010?ref=25">

    <title>US Marshalls Seize Caraco's Drug Products at Three Sites</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/US-Marshalls-Seize-Caracos-Drug-Products-at-Three-/ArticleStandard/Article/detail/608010?ref=25</link>

    <description>On June 25, US Marshalls seized all drug products and ingredients at three facilities of Caraco
    Pharmaceutical Laboratories.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/608010null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Technology-Approaches-to-Quality-Management---Spar/ArticleStandard/Article/detail/608577?ref=25">

    <title>Technology Approaches to Quality Management - Sparta Whitepaper</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Technology-Approaches-to-Quality-Management---Spar/ArticleStandard/Article/detail/608577?ref=25</link>

    <description>Technology Approaches to Quality Management - Sparta Whitepaper</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/608577null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/USP-Collaborates-with-Asian-Authorities/ArticleStandard/Article/detail/608009?ref=25">

    <title>USP Collaborates with Asian Authorities</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/USP-Collaborates-with-Asian-Authorities/ArticleStandard/Article/detail/608009?ref=25</link>

    <description>This week, the US Pharmacopeial Convention and the Vietnamese Pharmacopoeia Commission signed a
    memorandum of understanding that will help ensure the safety of Vietnamese medicines.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/608009null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/UK-Strengthens-Drug-Supply-Chain/ArticleStandard/Article/detail/608006?ref=25">

    <title>UK Strengthens Drug Supply Chain</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/UK-Strengthens-Drug-Supply-Chain/ArticleStandard/Article/detail/608006?ref=25</link>

    <description>The UK's Medicines and Healthcare Regulatory Agency (MHRA) has published the outcome of a consultation
    on measures to strengthen the country's drug supply chain.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/608006null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Cleaning-Validation-for-Pharmaceutical-Manufacturi/ArticleStandard/Article/detail/515954?ref=25">

    <title>Cleaning Validation for Pharmaceutical Manufacturing</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Cleaning-Validation-for-Pharmaceutical-Manufacturi/ArticleStandard/Article/detail/515954?ref=25</link>

    <description>Pharmaceutical manufacturers must validate cleaning processes and be compliant with current good
    manufacturing practices for finished pharmaceuticals as stated in 21 CFR Subpart D 211.67&amp;amp;mdash;equipment
    cleaning and maintenance. Validation is a documented guarantee that cleaning can be performed reliably and
    repeatedly to satisfy a predetermined level of cleanliness. This whitepaper addresses residue identification,
    residue detection method selection, sampling method selection, setting residue acceptance criteria, recovery
    studies, writing procedures and training operators.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/192008/515954null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Avoiding-Project-Delays-Caused-by-Formulation-Chan/ArticleStandard/Article/detail/607230?ref=25">

    <title>Avoiding Project Delays Caused by Formulation Changes</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Avoiding-Project-Delays-Caused-by-Formulation-Chan/ArticleStandard/Article/detail/607230?ref=25</link>

    <description>For pharmaceutical manufacturing companies, every decision in the product development process can
    impact the project outcome. By working closely with a reliable Contract Research Organization, clients can take the
    necessary precautions to avoid risks throughout the development program. A new white paper from SP Formulations,
    titled &amp;#34;Freeze! Avoid Catastrophic Project Delays Caused by Formulation Changes&amp;#34;, presents some of
    the problems associated with 'simple' formulation changes. In addition to providing guidance on outsourcing drug
    development needs, the white paper presents a case study detailing the alternative approaches available for
    formulating a lyophilized product.</description>

    <dc:date>2009-06-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607230null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Booth-Preview/ArticleStandard/Article/detail/607201?ref=25">
    <title>Booth Preview</title>

    <link>http://pharmtech.findpharma.com/pharmtech/Booth-Preview/ArticleStandard/Article/detail/607201?ref=25</link>

    <description />

    <dc:date>2009-06-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607201null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Watson-to-Acquire-Arrow-for-175-Billion/ArticleStandard/Article/detail/606176?ref=25">

    <title>Watson to Acquire Arrow for $1.75 Billion</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Watson-to-Acquire-Arrow-for-175-Billion/ArticleStandard/Article/detail/606176?ref=25</link>

    <description>Generic-drug and specialty pharmaceutical manufacturer Watson Pharmaceuticals (Corona, CA) agreed to
    acquire the generic-drug company Arrow Group for $1.75 billion in cash and stock.</description>

    <dc:date>2009-06-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/606176null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Aqueous-Cleaning-for-Pharmaceutical-Applications/ArticleStandard/Article/detail/476613?ref=25">

    <title>Aqueous Cleaning for Pharmaceutical Applications</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Aqueous-Cleaning-for-Pharmaceutical-Applications/ArticleStandard/Article/detail/476613?ref=25</link>

    <description>To streamline regulatory compliance, the desirability of using as few cleaners as possible to remove
    the entire range of residues encountered in pharmaceutical manufacturing &amp;amp;mdash; from water-soluble
    excipients to difficult-to-clean petrolatum/metal oxide mixtures &amp;amp;mdash; is explored in the standard
    industry text, The Aqueous Cleaning Handbook. Cleaning validation guidelines and key factors in establishing sound
    GMP and cGMP procedures are discussed. Explaining how aqueous cleaners work in a wide range of cleaning procedures,
    the text covers manual, soak and ultrasonic cleaning as well as clean-in-place (CIP) spray systems. Tables for
    chemical formulations, types of cleaning methods, and aqueous cleaning agents are included. A useful, in-depth
    reference whether you are cleaning bench scale lab apparatus used for trials to full-scale bulk manufacturing
    equipment.</description>

    <dc:date>2009-06-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/482007/476613null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/Former-Senate-Leaders-Support-Follow-On-Biologics-/ArticleStandard/Article/detail/606161?ref=25">

    <title>Former Senate Leaders Support Follow-On Biologics Pathway, Comparative Effectiveness Research</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/Former-Senate-Leaders-Support-Follow-On-Biologics-/ArticleStandard/Article/detail/606161?ref=25</link>

    <description>Former Senator Majority Leaders Howard Baker, Tom Daschle, and Bob Dole released a report this month,
    Crossing Our Line: Working Together to Reform the US Health System, which proposes four pillars of health
    reform.</description>

    <dc:date>2009-06-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/606161null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Sunshine-Act-Still-Pending-before-Senate-Committee/ArticleStandard/Article/detail/606159?ref=25">

    <title>Sunshine Act Still Pending before Senate Committee</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Sunshine-Act-Still-Pending-before-Senate-Committee/ArticleStandard/Article/detail/606159?ref=25</link>

    <description>The Physician Payments Sunshine Act is still pending before the US Senate Committee on Finance,
    according to Jill Kozeny, communications director for Senator Chuck Grassley (R-IA).</description>

    <dc:date>2009-06-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/606159null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/European-Fine-Chemicals-Group-Issues-Assessment-To/ArticleStandard/Article/detail/606178?ref=25">

    <title>European Fine Chemicals Group Issues Assessment Tool to Promote Supply-Chain Security</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/European-Fine-Chemicals-Group-Issues-Assessment-To/ArticleStandard/Article/detail/606178?ref=25</link>

    <description>Following the 2008 launch of the European Fine Chemicals Group (EFCG) Voluntary Guidelines (VGs) to
    promote supply-chain security, the group has now announced the official launch of an assessment template that will
    allow fine chemicals customers and suppliers to assess and implement this new set of recommendations.</description>

    <dc:date>2009-06-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/606178null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Synta-and-GSK-End-Agreeme/ArticleStandard/Article/detail/606500?ref=25">

    <title>Company and People Notes: Synta and GSK End Agreement; WuXi Appoints US VP; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Synta-and-GSK-End-Agreeme/ArticleStandard/Article/detail/606500?ref=25</link>

    <description>Also, Adimab forms deals with Merck and Roche; Manhattan Pharmaceuticals' CEO and president steps
    down; more...</description>

    <dc:date>2009-06-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/606500null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/New-FDA-and-ICH-Guidelines/ArticleStandard/Article/detail/605406?ref=25">

    <title>New FDA and ICH Guidelines</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/New-FDA-and-ICH-Guidelines/ArticleStandard/Article/detail/605406?ref=25</link>

    <description>This section lists final and draft guidances issued by the US Food and Drug Administration and the
    International Conference on Harmonization from Jan. 2008 through Apr. 2009.</description>

    <dc:date>2009-06-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/605406null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Avoiding-Project-Delays-Caused-by-Formulation-Chan/ArticleStandard/Article/detail/605324?ref=25">

    <title>Avoiding Project Delays Caused by Formulation Changes-SP Formulations Whitepaper</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Avoiding-Project-Delays-Caused-by-Formulation-Chan/ArticleStandard/Article/detail/605324?ref=25</link>

    <description>Avoiding Project Delays Caused by Formulation Changes-SP Formulations Whitepaper</description>

    <dc:date>2009-06-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/605324null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Approved-New-Molecular-Entities/ArticleStandard/Article/detail/605350?ref=25">

    <title>Approved New Molecular Entities</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Approved-New-Molecular-Entities/ArticleStandard/Article/detail/605350?ref=25</link>

    <description>This section of PharmTech's 2009 Industry Almanac lists the approved new molecular entities from Jan.
    2008 through Apr. 2009. The company names, brand names, dosage forms, and indications are included.</description>

    <dc:date>2009-06-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/605350null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Industry-Spending-Facts/ArticleStandard/Article/detail/605416?ref=25">

    <title>Industry Spending Facts</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Industry-Spending-Facts/ArticleStandard/Article/detail/605416?ref=25</link>

    <description>This section reviews key issues regarding equipment and machinery spending, including a comparison of
    actual 2008 spending and projected 2009 spending.</description>

    <dc:date>2009-06-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/605416null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/FDA-Commissioner-Hamburg-Discusses-Drug-Regulation/ArticleStandard/Article/detail/605500?ref=25">

    <title>FDA Commissioner Hamburg Discusses Drug Regulation</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/FDA-Commissioner-Hamburg-Discusses-Drug-Regulation/ArticleStandard/Article/detail/605500?ref=25</link>

    <description>The new commissioner of the US Food and Drug Administration is mapping plans for turning around an
    agency that has been demoralized, buffeted about in the press and has lost some of the trust of the American
    people.</description>

    <dc:date>2009-06-22T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/605500/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/605500null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Industry-Events-for-2009ndash2010/ArticleStandard/Article/detail/605349?ref=25">

    <title>Industry Events for 2009&amp;amp;ndash;2010</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Industry-Events-for-2009ndash2010/ArticleStandard/Article/detail/605349?ref=25</link>

    <description>This section of the almanac features upcoming events for 2009 and 2010.</description>

    <dc:date>2009-06-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/605349null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/FTC-Report-on-Follow-on-Biologics-Sparks-Congressi/ArticleStandard/Article/detail/604402?ref=25">

    <title>FTC Report on Follow-on Biologics Sparks Congressional Debate</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/FTC-Report-on-Follow-on-Biologics-Sparks-Congressi/ArticleStandard/Article/detail/604402?ref=25</link>

    <description>The Subcommittee on Health of the US House of Representatives Energy and Commerce Committee held
    hearings last week to discuss the findings of a report by the Federal Trade Commission (FTC) that examined the
    competitive effects for follow-on-biologics (FOBs).</description>

    <dc:date>2009-06-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252009/604402null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Harmonization-Steps-Move-Forward-in-Tokyo/ArticleStandard/Article/detail/604405?ref=25">

    <title>Harmonization Steps Move Forward in Tokyo</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Harmonization-Steps-Move-Forward-in-Tokyo/ArticleStandard/Article/detail/604405?ref=25</link>

    <description>Last week, the steering committee and expert working groups of the International Conference on
    Harmonization met in Yokohama, Japan, to discuss pending guidelines and other relevant issues.</description>

    <dc:date>2009-06-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252009/604405null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Industry-Health-Agencies-Respond-to-Influenza-Pand/ArticleStandard/Article/detail/604398?ref=25">

    <title>Industry, Health Agencies Respond to Influenza Pandemic</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Industry-Health-Agencies-Respond-to-Influenza-Pand/ArticleStandard/Article/detail/604398?ref=25</link>

    <description>Following the World Health Organization's declaration last week of an influenza pandemic, vaccine
    makers in Europe and China as well as world health agencies are stepping up efforts toward rapid development and
    approval of an effective vaccine.</description>

    <dc:date>2009-06-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252009/604398null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Dr-Reddy-and-GSK-Form-Pac/ArticleStandard/Article/detail/604472?ref=25">

    <title>Company and People Notes: Dr. Reddy and GSK Form Pact; Hollis-Eden Appoints CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Dr-Reddy-and-GSK-Form-Pac/ArticleStandard/Article/detail/604472?ref=25</link>

    <description>Also, FDA debars clinical investigators; Jubilant Organosys forms deal with Endo Pharmaceuticals; AMRI
    makes changes to its India management team; more...</description>

    <dc:date>2009-06-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252009/604472null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Could-We-Make-Large-Molecules-with-Less-Labor/ArticleStandard/Article/detail/603746?ref=25">

    <title>Could We Make Large Molecules with Less Labor?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Could-We-Make-Large-Molecules-with-Less-Labor/ArticleStandard/Article/detail/603746?ref=25</link>

    <description>The emergence of influenza A (H1N1) and the efforts to provide vaccines to the vulnerable are timely
    examples of biopharmaceuticals' continuing importance.</description>

    <dc:date>2009-06-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252009/603746null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/June-2009-Editors-Picks-Products-from-Bullard-and-/ArticleStandard/Article/detail/603608?ref=25">

    <title>June 2009 Editor's Picks: Products from Bullard and Teledyne Tekmar</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/June-2009-Editors-Picks-Products-from-Bullard-and-/ArticleStandard/Article/detail/603608?ref=25</link>

    <description>PharmTech's monthly newsletter, Equipment &amp;amp;amp; Processing Report, reviews the Editor's Picks
    for the May 2009 edition from Bullard and Teledyne Tekmar.</description>

    <dc:date>2009-06-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252009/603608null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation/Draft-Guidance-Issued-for-Injectors-Development/ArticleStandard/Article/detail/603740?ref=25">

    <title>Draft Guidance Issued for Injectors Development</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation/Draft-Guidance-Issued-for-Injectors-Development/ArticleStandard/Article/detail/603740?ref=25</link>

    <description>To address the increasing popularity of drug-injector systems, the US Food and Drug Administration
    last week released a Draft Guidance for Industry titled, Technical Considerations for Pen, Jet, and Related
    Injectors Intended for Use with Drugs and Biological Products.</description>

    <dc:date>2009-06-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252009/603740null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Kemwell-To-Build-Biologics-Manufacturing-Facility-/ArticleStandard/Article/detail/602702?ref=25">

    <title>Kemwell To Build Biologics Manufacturing Facility with Boehringer Ingelheim in India</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Kemwell-To-Build-Biologics-Manufacturing-Facility-/ArticleStandard/Article/detail/602702?ref=25</link>

    <description>Kemwell (Bangalore, Karnataka, India) plans to build a new biopharmaceutical manufacturing plant in
    Bangalore, India, in a strategic collaboration with Boehringer Ingelheim (BI, Ingelheim, Germany), according to a
    Kemwell press release.</description>

    <dc:date>2009-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602702null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Mylan-COO-Testifies-on-Pay-to-Delay-Patent-Settlem/ArticleStandard/Article/detail/602700?ref=25">

    <title>Mylan COO Testifies on Pay-to-Delay Patent Settlements</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Mylan-COO-Testifies-on-Pay-to-Delay-Patent-Settlem/ArticleStandard/Article/detail/602700?ref=25</link>

    <description>The chief operating officer (COO) of Mylan (Canonsburg, PA), one of the world's leading generic drug
    manufacturers, has condemned the launch of authorized generic drugs during 180-day exclusivity
    periods.</description>

    <dc:date>2009-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602700null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/GAO-Recommends-That-FDA-Ensure-Data-Security-withi/ArticleStandard/Article/detail/602699?ref=25">

    <title>GAO Recommends That FDA Ensure Data Security within the Sentinel System</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/GAO-Recommends-That-FDA-Ensure-Data-Security-withi/ArticleStandard/Article/detail/602699?ref=25</link>

    <description>The US Government Accountability Office recommended that the US Food and Drug Administration draft a
    plan, including milestones, for developing its Sentinel system and ensuring the privacy and security of patients'
    healthcare data.</description>

    <dc:date>2009-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602699null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/European-Commission-Wont-Pursue-Directive-for-Exci/ArticleStandard/Article/detail/602697?ref=25">

    <title>European Commission Won't Pursue Directive for Excipient GMPs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/European-Commission-Wont-Pursue-Directive-for-Exci/ArticleStandard/Article/detail/602697?ref=25</link>

    <description>The European Commission's (EC) Directorate-General for Enterprise and Industry (EC-DG Enterprise)
    announced last week that it will not continue preparing a commission directive on good manufacturing practices
    (GMPs) for certain excipients.</description>

    <dc:date>2009-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602697null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-and-Talecris-Terminat/ArticleStandard/Article/detail/602720?ref=25">

    <title>Company and People Notes: CSL and Talecris Terminate Merger Agreement; Eli Lilly Hires Former Indianapolis
    Mayor; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-and-Talecris-Terminat/ArticleStandard/Article/detail/602720?ref=25</link>

    <description>Also, TorreyPines Therapeutics to liquidate assets and dissolve company; EU's competition services to
    examine Pfizer/Wyeth merger; Akorn appoints Raj Rai interim CEO; more...</description>

    <dc:date>2009-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602720null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/Report-From-India-A-new-patent-battleground-has-fo/ArticleStandard/Article/detail/603163?ref=25">

    <title>Report From India: A new patent battleground has formed over India's drug shipments through the European
    Union.</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/Report-From-India-A-new-patent-battleground-has-fo/ArticleStandard/Article/detail/603163?ref=25</link>

    <description>Patent infringement claims and a lack of clear global trade distribution routes may be unraveling the
    country's generic-drug export industry.</description>

    <dc:date>2009-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/603163null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Draft-Guidance-Issued-for-Injectors-Development/ArticleStandard/Article/detail/602698?ref=25">

    <title>Draft Guidance Issued for Injectors Development</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Draft-Guidance-Issued-for-Injectors-Development/ArticleStandard/Article/detail/602698?ref=25</link>

    <description>To address the increasing popularity of drug-injector systems, the US Food and Drug Administration
    last week released a Draft Guidance for Industry titled, Technical Considerations for Pen, Jet, and Related
    Injectors Intended for Use with Drugs and Biological Products.</description>

    <dc:date>2009-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602698null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/FDA-Issues-Guidance-on-Medication-Guide-Statements/ArticleStandard/Article/detail/602695?ref=25">

    <title>FDA Issues Guidance on Medication Guide Statements</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/FDA-Issues-Guidance-on-Medication-Guide-Statements/ArticleStandard/Article/detail/602695?ref=25</link>

    <description>The US Food and Drug Administration released a new guidance for industry, Medication Guides-Adding a
    Toll-Free Number for Reporting Adverse Events, on June 8, 2009.</description>

    <dc:date>2009-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602695null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/MHRA-Seeks-Improved-Legislative-Framework/ArticleStandard/Article/detail/602701?ref=25">

    <title>MHRA Seeks Improved Legislative Framework</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/MHRA-Seeks-Improved-Legislative-Framework/ArticleStandard/Article/detail/602701?ref=25</link>

    <description>The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has published the results of its
    concept paper that sought comments regarding the review and consolidation of the UK medicines
    legislation.</description>

    <dc:date>2009-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602701null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Best-Practices-in-the-Supply-Chain/ArticleStandard/Article/detail/601481?ref=25">

    <title>Best Practices in the Supply Chain</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Best-Practices-in-the-Supply-Chain/ArticleStandard/Article/detail/601481?ref=25</link>

    <description>Consumer-care products, electronics, and select industrial firms comprise AMR Research's Supply Chain
    Top 25 for 2009, offering an opportunity for the pharmaceutical industry to examine best practices in supply-chain
    management.</description>

    <dc:date>2009-06-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601481null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Bleak-Times-for-the-Global-Biotech-Industry/ArticleStandard/Article/detail/601471?ref=25">

    <title>Bleak Times for the Global Biotech Industry</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Bleak-Times-for-the-Global-Biotech-Industry/ArticleStandard/Article/detail/601471?ref=25</link>

    <description>The US biotechnology industry reached aggregate profitability for the first time ever in 2008,
    representing the only bright spot in an otherwise dismal year for biotechnology financing and
    performance.</description>

    <dc:date>2009-06-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601471null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Limits-to-Growth/ArticleStandard/Article/detail/601914?ref=25">

    <title>Limits to Growth?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Limits-to-Growth/ArticleStandard/Article/detail/601914?ref=25</link>

    <description>A major CRO ventures further into proprietary drug development.</description>

    <dc:date>2009-06-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601914null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/THE-IMPORTANCE-OF-ON-DOSE-TECHNOLOGIES-IN-THE-FIGH/ArticleStandard/Article/detail/601784?ref=25">

    <title>THE IMPORTANCE OF ON-DOSE TECHNOLOGIES IN THE FIGHT AGAINST MISUSE, ABUSE AND ILLEGAL DIVERSION OF
    OPIOIDS-NanoGuardian Applicaion Note</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/THE-IMPORTANCE-OF-ON-DOSE-TECHNOLOGIES-IN-THE-FIGH/ArticleStandard/Article/detail/601784?ref=25</link>

    <description>THE IMPORTANCE OF ON-DOSE TECHNOLOGIES IN THE FIGHT AGAINST MISUSE, ABUSE AND ILLEGAL DIVERSION OF
    OPIOIDS-NanoGuardian Applicaion Note</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601784null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/House-Introduces-Discussion-Draft-for-Drug-and-Foo/ArticleStandard/Article/detail/601252?ref=25">

    <title>House Introduces Discussion Draft for Drug and Food Safety</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/House-Introduces-Discussion-Draft-for-Drug-and-Foo/ArticleStandard/Article/detail/601252?ref=25</link>

    <description>Members of the House Committee on Energy and Commerce, Chair Emeritus John D. Dingell (D-MI), Chair
    Henry A. Waxman (D-CA), and Reps. Frank Pallone (D-NJ), Bart Stupak (D-MI), Diana DeGette (D-CO) and Betty Sutton
    (D-OH) released last week a discussion draft of the Food Safety Enhancement Act of 2009.</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601252null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/US-and-16-States-Sue-Wyeth-over-Medicaid-Discounts/ArticleStandard/Article/detail/601246?ref=25">

    <title>US and 16 States Sue Wyeth over Medicaid Discounts</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/US-and-16-States-Sue-Wyeth-over-Medicaid-Discounts/ArticleStandard/Article/detail/601246?ref=25</link>

    <description>In two whistleblower suits filed in May 2009, the United States and 16 states alleged that Wyeth
    (Madison, NJ) knowingly failed to offer the government the same discounts it gave to private purchasers of its
    drugs, as Medicaid laws require.</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601246null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-and-Merck-Col/ArticleStandard/Article/detail/601645?ref=25">

    <title>Company and People Notes: AstraZeneca and Merck Collaborate on Cancer Drug; Catalent Appoints Senior VP;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-and-Merck-Col/ArticleStandard/Article/detail/601645?ref=25</link>

    <description>Also, WACKER expands Iowa facility; EMEA releases a Q&amp;amp;amp;A document for PIPs; Metrics
    consolidates quality operations; more...</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601645null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/EU-May-Change-Direct-to-Consumer-Rules/ArticleStandard/Article/detail/601259?ref=25">

    <title>EU May Change Direct-to-Consumer Rules</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/EU-May-Change-Direct-to-Consumer-Rules/ArticleStandard/Article/detail/601259?ref=25</link>

    <description>The United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) is seeking opinions on
    a European Commission (EC) proposal that would allow drugmakers to disseminate certain information on prescription
    medicines directly to European Union patients.</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601259null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/FDA-Issues-Guidance-on-Submitting-Establishment-Re/ArticleStandard/Article/detail/601247?ref=25">

    <title>FDA Issues Guidance on Submitting Establishment Registrations Electronically</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/FDA-Issues-Guidance-on-Submitting-Establishment-Re/ArticleStandard/Article/detail/601247?ref=25</link>

    <description>This week the US Food and Drug Administration released the final version of Guidance for Industry:
    Providing Regulatory Submissions in Electronic Format-Drug Establishment Registration and Drug
    Listing.</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601247null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Genetic-Link-to-Drug-Induced-Liver-Injury-Found/ArticleStandard/Article/detail/601260?ref=25">

    <title>Genetic Link to Drug-Induced Liver Injury Found</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Genetic-Link-to-Drug-Induced-Liver-Injury-Found/ArticleStandard/Article/detail/601260?ref=25</link>

    <description>The International Serious Adverse Event Consortium (SAEC), a nonprofit partnership, has helped the US
    Food and Drug Administration gain significant understanding of the genetic basis for drug-induced liver injury,
    according a new FDA press release.</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601260null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Drug-Serialization-and-Supply-Chain-Security/ArticleStandard/Article/detail/601169?ref=25">

    <title>Drug Serialization and Supply-Chain Security</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Drug-Serialization-and-Supply-Chain-Security/ArticleStandard/Article/detail/601169?ref=25</link>

    <description>As regulators work to curb counterfeiting, industry finds benefits to gaining granular data about the
    supply chain. This article contains bonus online-exclusive material.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601169/Bonus_main.gif</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601169/rotate_counterfeiting_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Mapping-Opportunities-for-Patent-Positions/ArticleStandard/Article/detail/600805?ref=25">

    <title>Mapping Opportunities for Patent Positions</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Mapping-Opportunities-for-Patent-Positions/ArticleStandard/Article/detail/600805?ref=25</link>

    <description>Follow-on biologics could unleash the potential of several industries and may even spark economic
    recovery.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600805null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation+Article/Operator-Error/ArticleStandard/Article/detail/600806?ref=25">

    <title>Operator Error</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation+Article/Operator-Error/ArticleStandard/Article/detail/600806?ref=25</link>

    <description>Short-term problems in software or hardware lead to long-term manufacturing troubles.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600806null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Testing+Article/Charting-a-Pathway-to-Follow-On-Biologics/ArticleStandard/Article/detail/600817?ref=25">

    <title>Charting a Pathway to Follow-On Biologics</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Testing+Article/Charting-a-Pathway-to-Follow-On-Biologics/ArticleStandard/Article/detail/600817?ref=25</link>

    <description>Debates about science, manufacturing, and European regulations will shape the approval process for
    follow-on biologics in the United States.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600817/rotate_cover_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Report-From-Ireland/ArticleStandard/Article/detail/600811?ref=25">

    <title>Report From: Ireland</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Report-From-Ireland/ArticleStandard/Article/detail/600811?ref=25</link>

    <description>Despite its shrinking domestic economy, Ireland is determined not to let its pharmaceutical industry
    fade into the shadow of global recession.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600811null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Inside+Standards/Quality-Trio-Takes-Final-Shape/ArticleStandard/Article/detail/600815?ref=25">

    <title>Quality Trio Takes Final Shape</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Inside+Standards/Quality-Trio-Takes-Final-Shape/ArticleStandard/Article/detail/600815?ref=25</link>

    <description>FDA leaders explain the purpose and plan for ICH's three quality guidelines.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600815null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/In-the-Spotlight/ArticleStandard/Article/detail/600810?ref=25">

    <title>In the Spotlight</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/In-the-Spotlight/ArticleStandard/Article/detail/600810?ref=25</link>

    <description>Editors' Picks of Pharmaceutical Science &amp;amp;amp; Technology Innovations</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600810null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Package-Design-Boosts-Patient-Compliance/ArticleStandard/Article/detail/600816?ref=25">

    <title>Package Design Boosts Patient Compliance</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Package-Design-Boosts-Patient-Compliance/ArticleStandard/Article/detail/600816?ref=25</link>

    <description>Compliance features help patients follow medication regimens correctly.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600816/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600816null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/Quarantine-at-a-Glance/ArticleStandard/Article/detail/601628?ref=25">

    <title>Quarantine at a Glance</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/Quarantine-at-a-Glance/ArticleStandard/Article/detail/601628?ref=25</link>

    <description>A successful quarantine program requires collaboration among all departments of a pharmaceutical
    facility.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601628/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601628null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Pharma-Capsules/ArticleStandard/Article/detail/600813?ref=25">

    <title>Pharma Capsules</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Pharma-Capsules/ArticleStandard/Article/detail/600813?ref=25</link>

    <description>Brief pharmaceutical news items for June 2009.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600813null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Beneath-the-Surface/ArticleStandard/Article/detail/600812?ref=25">

    <title>Beneath the Surface</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Beneath-the-Surface/ArticleStandard/Article/detail/600812?ref=25</link>

    <description>It can take a lot of work to make sure nothing happens.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600812null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Quality-in-Quality-Out/ArticleStandard/Article/detail/601167?ref=25">

    <title>Quality in, Quality Out</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Quality-in-Quality-Out/ArticleStandard/Article/detail/601167?ref=25</link>

    <description>A book guides readers through the regulatory requirements for computerized quality
    systems.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601167/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601167null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Truth-and-Transparency/ArticleStandard/Article/detail/600808?ref=25">

    <title>Truth and Transparency</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Truth-and-Transparency/ArticleStandard/Article/detail/600808?ref=25</link>

    <description>Misleading the public about their investments&amp;amp;mdash;be it money or medicine&amp;amp;mdash;is
    unacceptable.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600808null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Outsourcing-Clinical-Trial-Materials/ArticleStandard/Article/detail/600809?ref=25">

    <title>Outsourcing Clinical Trial Materials</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Outsourcing-Clinical-Trial-Materials/ArticleStandard/Article/detail/600809?ref=25</link>

    <description>CROs and CMOs expand to gain a piece of the market for clinical trial materials.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600809/rotate_ingredients_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/FDA-Waves-a-Big-Stick/ArticleStandard/Article/detail/600814?ref=25">

    <title>FDA Waves a Big Stick</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/FDA-Waves-a-Big-Stick/ArticleStandard/Article/detail/600814?ref=25</link>

    <description>Agency officials and manufacturers anticipate stricter enforcement of drug safety and
    quality.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600814null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Penny-Wise-Pound-Foolish/ArticleStandard/Article/detail/600807?ref=25">

    <title>Penny-Wise, Pound-Foolish</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Penny-Wise-Pound-Foolish/ArticleStandard/Article/detail/600807?ref=25</link>

    <description>Pharma companies that sell redundant facilities could endanger their supply chains.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600807null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Initial-Solvent-Screening-of-Carbamazepine-Cimetid/ArticleStandard/Article/detail/601168?ref=25">

    <title>Initial Solvent Screening of Carbamazepine, Cimetidine, and Phenylbutazone: Part 2 of 2</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Initial-Solvent-Screening-of-Carbamazepine-Cimetid/ArticleStandard/Article/detail/601168?ref=25</link>

    <description>The authors describe the importance of a rapid and an abbreviated screening strategy in initial
    solvent screening. This article contains bonus online-exclusive material.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601168/Bonus_main.gif</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601168null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Pharmacosomes-A-Potential-Alternative-to-Conventio/ArticleStandard/Article/detail/601891?ref=25">

    <title>Pharmacosomes: A Potential Alternative to Conventional Vesicular Systems</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Pharmacosomes-A-Potential-Alternative-to-Conventio/ArticleStandard/Article/detail/601891?ref=25</link>

    <description>Pharmacosomes can pass through biomembranes efficiently and possess several advantages over
    traditional vesicular drug-delivery systems.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601891null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Bulk-Inspection-of-Tablets-Symetix-Applicaton-Note/ArticleStandard/Article/detail/601279?ref=25">

    <title>Bulk Inspection of Tablets-Symetix Applicaton Note</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Bulk-Inspection-of-Tablets-Symetix-Applicaton-Note/ArticleStandard/Article/detail/601279?ref=25</link>

    <description>Bulk Inspection of Tablets-Symetix Applicaton Note</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601279null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/FDAs-Question-Based-Review-Initiative-for-Generic-/ArticleStandard/Article/detail/600572?ref=25">

    <title>FDA Office of Generic Drugs Question-Based Review Initiative: An Update</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/FDAs-Question-Based-Review-Initiative-for-Generic-/ArticleStandard/Article/detail/600572?ref=25</link>

    <description>The Question-Based Review (QbR) initiative of the Office of Generic Drugs has reached its second full
    year in 2009. Special from the Journal of Validation Technology.</description>

    <dc:date>2009-05-29T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600572/fda_small_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600572/fda_button_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/Attorney-Sentenced-to-Jail-for-Illegally-Distribut/ArticleStandard/Article/detail/600069?ref=25">

    <title>Attorney Sentenced to Jail for Illegally Distributing HIV Drug</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/Attorney-Sentenced-to-Jail-for-Illegally-Distribut/ArticleStandard/Article/detail/600069?ref=25</link>

    <description>Last week, the US District Court in Concord, New Hampshire, sentenced 63-year-old Robert McFadden, an
    attorney from Palm Springs, CA, to three years of incarceration to be followed by two years of supervised release
    for participating in the purchase and distribution of the HIV drug Serostim (somatropin recombinant), according to
    a US Department of Justice press release.</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600069null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-Forms-Licensing-Ag/ArticleStandard/Article/detail/600299?ref=25">

    <title>Company and People Notes: Pfizer Forms Licensing Agreements; Malvinder Mohan Singh Steps Down at Ranbaxy,
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-Forms-Licensing-Ag/ArticleStandard/Article/detail/600299?ref=25</link>

    <description>Also, Johnson &amp;amp;amp; Johnson acquires Cougar Biotechnology; NIH launches program for rare and
    neglected diseases; PPD restructures leadership positions; more...</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600299null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Static-Electricity-The-Hidden-Danger/ArticleStandard/Article/detail/600996?ref=25">

    <title>Static Electricity, The Hidden Danger</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Static-Electricity-The-Hidden-Danger/ArticleStandard/Article/detail/600996?ref=25</link>

    <description>Static Electricity is an ever-present hazard for operations and processes taking place in flammable or
    combustible locations. Sparking caused by electrostatic can provide an ignition source for gases, vapors and dust
    atmospheres. This article explains the background to the hazards of static electricity and provides some guidance
    as to how they may be safely avoided.</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/600996null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Tablet-Pro/ArticleStandard/Article/detail/517506?ref=25">

    <title>Tablet Pro</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Tablet-Pro/ArticleStandard/Article/detail/517506?ref=25</link>

    <description>Tablet Pro defines Tablet Compression in detail and its relationship to each of the manufacturing
    steps in preparing the formulation for compress, proper compression operations and the essence of making quality
    tablets.</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/202008/517506null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Novartis-Gains-Exclusive-Option-to-Acquire-Elixir-/ArticleStandard/Article/detail/600067?ref=25">

    <title>Novartis Gains Exclusive Option to Acquire Elixir Pharmaceuticals</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Novartis-Gains-Exclusive-Option-to-Acquire-Elixir-/ArticleStandard/Article/detail/600067?ref=25</link>

    <description>Novartis (Basel) signed an agreement that grants the company an exclusive option to acquire Elixir
    Pharmaceuticals (Cambridge, MA) upon the successful completion of a Phase IIa clinical study of Elixir's lead oral
    ghrelin antagonist, which is now the subject of preclinical studies.</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600067null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/HHS-Orders-H1N1-Vaccines-and-Vaccine-Antigen/ArticleStandard/Article/detail/600054?ref=25">

    <title>HHS Orders H1N1 Vaccines and Vaccine Antigen</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/HHS-Orders-H1N1-Vaccines-and-Vaccine-Antigen/ArticleStandard/Article/detail/600054?ref=25</link>

    <description>The United States Department of Health and Human Services (HHS) this week placed an initial order with
    Sanofi Pasteur (Lyon, France) for a vaccine to fight influenza A (H1N1) infection.</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600054null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/ADM-Plans-Green-Production-for-USP-Grade-Propylene/ArticleStandard/Article/detail/600065?ref=25">

    <title>ADM Plans Green Production for USP-Grade Propylene Glycol</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/ADM-Plans-Green-Production-for-USP-Grade-Propylene/ArticleStandard/Article/detail/600065?ref=25</link>

    <description>Archers Daniel Midland Company (Decatur, IL) is bringing on line a new propylene glycol plant in
    Decatur, Illinois, in the fourth quarter of 2009.</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600065null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Static-Electricity-The-Hidden-Danger-Newson-Gale-W/ArticleStandard/Article/detail/600448?ref=25">

    <title>Static Electricity, The Hidden Danger-Newson Gale Whitepaper</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Static-Electricity-The-Hidden-Danger-Newson-Gale-W/ArticleStandard/Article/detail/600448?ref=25</link>

    <description>Static Electricity, The Hidden Danger-Newson Gale Whitepaper</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600448null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Issues-Draft-Guidance-on-Presenting-Risk-Infor/ArticleStandard/Article/detail/600057?ref=25">

    <title>FDA Issues Draft Guidance on Presenting Risk Information in Promotional Materials</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Issues-Draft-Guidance-on-Presenting-Risk-Infor/ArticleStandard/Article/detail/600057?ref=25</link>

    <description>The US Food and Drug Administration posted a draft guidance for industry, Presenting Risk Information
    in Prescription Drug and Medical Device Promotion, on its website May 26, that describes factors the agency
    considers when evaluating advertisements and promotional labeling for prescription drugs and medical
    devices.</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600057null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/EFPIA-to-Launch-Anticounterfeiting-Pilot-in-Sweden/ArticleStandard/Article/detail/600062?ref=25">

    <title>EFPIA to Launch Anticounterfeiting Pilot in Sweden</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/EFPIA-to-Launch-Anticounterfeiting-Pilot-in-Sweden/ArticleStandard/Article/detail/600062?ref=25</link>

    <description>The European Federation of Pharmaceutical Industries and Associations (EFPIA) announced a pilot
    program, to launch in Sweden later this year, that will focus on coding and identification solutions.</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600062null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/USP-lt231gt-Heavy-Metals-Webcast/ArticleStandard/Article/detail/600132?ref=25">

    <title>USP &amp;amp;lt;231&amp;amp;gt; Heavy Metals Webcast</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/USP-lt231gt-Heavy-Metals-Webcast/ArticleStandard/Article/detail/600132?ref=25</link>

    <description>The US Pharmacopeia will release for public comment a new USP &amp;amp;lt;231&amp;amp;gt; Heavy Metals
    general chapter. Is your laboratory ready to handle the changes? Find out at Pharmaceutical Technology's June 4
    webinar. And check out our interactive metals and limits table.</description>

    <dc:date>2009-05-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600132/HeavyMetals_rotate_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Versatrol-Controlled-Release-Softgel-Drug-Delivery/ArticleStandard/Article/detail/599418?ref=25">

    <title>Versatrol Controlled Release Softgel Drug Delivery-Banner Application Note</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Versatrol-Controlled-Release-Softgel-Drug-Delivery/ArticleStandard/Article/detail/599418?ref=25</link>

    <description>Versatrol Controlled Release Softgel Drug Delivery-Banner Application Note</description>

    <dc:date>2009-05-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/599418null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/PhRMA-Supports-Obamas-Healthcare-Reform-Initiative/ArticleStandard/Article/detail/599063?ref=25">

    <title>PhRMA Supports Obama's Healthcare-Reform Initiative</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/PhRMA-Supports-Obamas-Healthcare-Reform-Initiative/ArticleStandard/Article/detail/599063?ref=25</link>

    <description>Last Monday, Billy Tauzin, president and CEO of the Pharmaceutical Research and Manufacturers of
    America (PhRMA), voiced the group's support for President Obama's efforts to reform the nation's healthcare
    system.</description>

    <dc:date>2009-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/599063null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Prefilled-Syringes-Growing-More-Popular/ArticleStandard/Article/detail/599068?ref=25">

    <title>Prefilled Syringes Growing More Popular</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Prefilled-Syringes-Growing-More-Popular/ArticleStandard/Article/detail/599068?ref=25</link>

    <description>According to a report from Greystone Associates in Amherst, New Hampshire, prefilled syringes are
    replacing vials both in terms of injections and sector revenue, and as this trend continues during the next four
    years, the number of tailored injectable drug products reaching the market is set to escalate.</description>

    <dc:date>2009-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/599068null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/EMEA-Releases-Draft-Advanced-Therapy-Medicinal-Pro/ArticleStandard/Article/detail/599061?ref=25">

    <title>EMEA Releases Draft Advanced Therapy Medicinal Product Procedures</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/EMEA-Releases-Draft-Advanced-Therapy-Medicinal-Pro/ArticleStandard/Article/detail/599061?ref=25</link>

    <description>The European Medicines Agency (EMEA) recently issued for public comment draft procedures on the
    evaluation of advanced therapy medicinal product (ATMPs).</description>

    <dc:date>2009-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/599061null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/European-Commission-Investigates-Biotech-Industry/ArticleStandard/Article/detail/599067?ref=25">

    <title>European Commission Investigates Biotech Industry</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/European-Commission-Investigates-Biotech-Industry/ArticleStandard/Article/detail/599067?ref=25</link>

    <description>More than 70% of biotechnology executives fear that the European Commission's (EC) examination of
    anticompetitive behavior in the pharmaceutical industry, which began in January 2008, will weaken their patent
    protection, according to a new Marks &amp;amp;amp; Clerk report.</description>

    <dc:date>2009-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/599067null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Pharmacia-May-Pay-212M-in-Medicaid-Fraud-Case/ArticleStandard/Article/detail/599057?ref=25">

    <title>Pharmacia May Pay $212M in Medicaid Fraud Case</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Pharmacia-May-Pay-212M-in-Medicaid-Fraud-Case/ArticleStandard/Article/detail/599057?ref=25</link>

    <description>Pfizer's Pharmacia unit may be ordered to pay nearly $212 million as a result of a February 2009
    Wisconsin court ruling that found the company guilty of violating the state's Medicaid fraud statute 1.44 million
    times.</description>

    <dc:date>2009-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/599057null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/WHO-GSK-Provide-Update-on-Pandemic-Flu-Production/ArticleStandard/Article/detail/599059?ref=25">

    <title>WHO, GSK Provide Update on Pandemic Flu Production</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/WHO-GSK-Provide-Update-on-Pandemic-Flu-Production/ArticleStandard/Article/detail/599059?ref=25</link>

    <description>The World Health Organization's Ad Hoc Policy Advisory Working Group on Influenza A (H1N1) Vaccines
    issued an update on May 18, 2009, on the production status of seasonal and A (H1NI) vaccines.</description>

    <dc:date>2009-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/599059null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Hamburg-to-Take-Hold-of-FDA/ArticleStandard/Article/detail/599052?ref=25">

    <title>Hamburg to Take Hold of FDA</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Hamburg-to-Take-Hold-of-FDA/ArticleStandard/Article/detail/599052?ref=25</link>

    <description>The Senate confirmed late Monday night Dr. Margaret A. Hamburg, 53, to lead the US Food and Drug
    Administration.</description>

    <dc:date>2009-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/599052null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Teva-and-Lonza-Joint-Vent/ArticleStandard/Article/detail/599148?ref=25">

    <title>Company and People Notes: Teva and Lonza Joint Venture Approved; Novartis CFO to Retire; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Teva-and-Lonza-Joint-Vent/ArticleStandard/Article/detail/599148?ref=25</link>

    <description>Also, Oxford BioTherapeutics forms drug development pact with GSK; Avila Therapeutics names CEO;
    more...</description>

    <dc:date>2009-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/599148null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Teaching-a-New-Robot-Old-Tricks/ArticleStandard/Article/detail/598567?ref=25">

    <title>Teaching a New Robot Old Tricks</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Teaching-a-New-Robot-Old-Tricks/ArticleStandard/Article/detail/598567?ref=25</link>

    <description>Automation has been part of pharmaceutical processing for some time, but robotics have not yet found
    wide acceptance among drugmakers.</description>

    <dc:date>2009-05-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/598567null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/May-2009-Editors-Picks-Products-from-Continental-D/ArticleStandard/Article/detail/598570?ref=25">

    <title>May 2009 Editor's Picks: Products from Continental Disc and Filimatic</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/May-2009-Editors-Picks-Products-from-Continental-D/ArticleStandard/Article/detail/598570?ref=25</link>

    <description>PharmTech's monthly newsletter, Equipment &amp;amp;amp; Processing Report, reviews the Editor's Picks
    for the May 2009 edition from Continental Disc and Filimatic.</description>

    <dc:date>2009-05-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/598570null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Pharmaceutical-Packaging-and-ePedigree-Requirement/ArticleStandard/Article/detail/598569?ref=25">

    <title>Pharmaceutical Packaging and ePedigree Requirements</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Pharmaceutical-Packaging-and-ePedigree-Requirement/ArticleStandard/Article/detail/598569?ref=25</link>

    <description>The US Food and Drug Administration intends to automate and enhance the safety of the pharmaceutical
    supply chain by establishing electronic pedigrees (ePedigrees) for drug products.</description>

    <dc:date>2009-05-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/598569null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Requests-Largest-Ever-Budget-Increase/ArticleStandard/Article/detail/597992?ref=25">

    <title>FDA Requests Largest-Ever Budget Increase</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Requests-Largest-Ever-Budget-Increase/ArticleStandard/Article/detail/597992?ref=25</link>

    <description>On May 7, 2009, as part of the President's fiscal year (FY) 2010 budget, the US Food and Drug
    Administration requested a budget of $3.2 billion, which is 19% more than the agency's current
    budget.</description>

    <dc:date>2009-05-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/202009/597992null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-Forms-Pact-with-Aspen/ArticleStandard/Article/detail/598063?ref=25">

    <title>Company and People Notes: GSK Forms Pact with Aspen Pharmacare; Sigma-Aldrich Chairman to Retire;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-Forms-Pact-with-Aspen/ArticleStandard/Article/detail/598063?ref=25</link>

    <description>Also, Takeda to consolidate operations in Ireland; FDA to redesign website; Archemix names president
    and CEO; more...</description>

    <dc:date>2009-05-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/202009/598063null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/THE-IMPORTANCE-OF-ON-DOSE-TECHNOLOGIES-IN-THE-FIGH/ArticleStandard/Article/detail/598516?ref=25">

    <title>THE IMPORTANCE OF ON-DOSE TECHNOLOGIES IN THE FIGHT AGAINST MISUSE, ABUSE AND ILLEGAL DIVERSION OF
    OPIOIDS</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/THE-IMPORTANCE-OF-ON-DOSE-TECHNOLOGIES-IN-THE-FIGH/ArticleStandard/Article/detail/598516?ref=25</link>

    <description>Pharmaceutical Security Expert Dr. John Glover Argues for On-Dose Brand Protection in the Fight
    Against Illegal Diversion of Opioid Medications to Prevent Misuse and Abuse</description>

    <dc:date>2009-05-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/202009/598516null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Sanofi-aventis-To-Build-New-Vaccine-Manufacturing-/ArticleStandard/Article/detail/597995?ref=25">

    <title>Sanofi-aventis To Build New Vaccine-Manufacturing Plant</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Sanofi-aventis-To-Build-New-Vaccine-Manufacturing-/ArticleStandard/Article/detail/597995?ref=25</link>

    <description>Sanofi-aventis announced this week that it plans to construct a new vaccine-manufacturing center in
    Neuville-sur-Sa&amp;amp;ocirc;ne, France.</description>

    <dc:date>2009-05-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/202009/597995null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/FDA-Issues-First-Sentinel-Initiative-Project-Repor/ArticleStandard/Article/detail/597996?ref=25">

    <title>FDA Issues First Sentinel Initiative Project Report: Statistical Methods</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/FDA-Issues-First-Sentinel-Initiative-Project-Repor/ArticleStandard/Article/detail/597996?ref=25</link>

    <description>The first project report on FDA's Sentinel website, discusses the evaluation of existing methods for
    safety signal identification.</description>

    <dc:date>2009-05-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/202009/597996null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/HPAPI-Manufacturing-Capability/ArticleStandard/Article/detail/598449?ref=25">

    <title>HPAPI Manufacturing Capability</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/HPAPI-Manufacturing-Capability/ArticleStandard/Article/detail/598449?ref=25</link>

    <description>Richman Chemical Inc. (RCI) has tapped its capable network of partners to now offer high potency
    chemical manufacturing in a cGMP environment to its customers. A high potency active pharmaceutical ingredient
    (HPAPI) is a drug that carries a higher strength with a smaller amount of actual active pharmaceutical ingredient.
    Maintaining safety and efficacy while responding to the time sensitive nature inherent to life science firms
    needing to manufacture these HPAPIs has placed RCI in a pivotal position to respond to this growing
    requirement.</description>

    <dc:date>2009-05-13T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/202009/598449null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Aqueous-Critical-Cleaning-in-Pharmaceutical-Manufa/ArticleStandard/Article/detail/515944?ref=25">

    <title>Aqueous Critical Cleaning in Pharmaceutical Manufacturing</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Aqueous-Critical-Cleaning-in-Pharmaceutical-Manufa/ArticleStandard/Article/detail/515944?ref=25</link>

    <description>This whitepaper examines the numerous benefits of using aqueous cleaning solutions in pharmaceutical
    manufacturing. It also reviews the important factors involved in the aqueous critical cleaning process that need to
    be considered by the pharmaceutical manufacturer.</description>

    <dc:date>2009-05-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/192008/515944null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Modern-tools-for-hopper-design/ArticleStandard/Article/detail/597324?ref=25">

    <title>Modern tools for hopper design</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Modern-tools-for-hopper-design/ArticleStandard/Article/detail/597324?ref=25</link>

    <description>Although there are well-established methodologies for hopper design, many process engineers are
    uncertain as to how to measure powders in the prescribed way, extract the necessary parameters from recorded data,
    and successfully apply them. As a result, hopper design and the powder testing associated with it is often
    outsourced to specialists. This incurs significant cost and undermines the operating company's ability to
    troubleshoot and re-use or retrofit equipment for alternative materials or applications.</description>

    <dc:date>2009-05-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/192009/597324null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/How-to-Make-a-Swine-Flu-Vaccine/ArticleStandard/Article/detail/597284?ref=25">

    <title>How to Make a Swine Flu Vaccine</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Exclusives/How-to-Make-a-Swine-Flu-Vaccine/ArticleStandard/Article/detail/597284?ref=25</link>

    <description>Covance talks about the risks, challenges, and tests required to develop a pandemic
    vaccine.</description>

    <dc:date>2009-05-08T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/192009/597284/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/192009/597284null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Sanofi-aventis-Plans-Biopharmaceutical-Investment/ArticleStandard/Article/detail/596941?ref=25">

    <title>Sanofi-aventis Plans Biopharmaceutical Investment</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Sanofi-aventis-Plans-Biopharmaceutical-Investment/ArticleStandard/Article/detail/596941?ref=25</link>

    <description>Sanofi-aventis introduced this week its Biolaunch project at its Vitry-sur-Seine, France,
    pharmaceutical production site.</description>

    <dc:date>2009-05-07T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/192009/596941null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>
</rdf:RDF>


